$2.95
0.134.61%
最終更新: Oct 22, 8:53 AM
Benzinga
Benzinga
Benzinga
金曜日, 10 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Lexaria Bioscience (LEXX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.90 | $-1.20 | $-1.20 | $-2.40 |
| Actual | $-1.20 | $-0.90 | $-1.05 | $-1.95 |
| Surprise | -33.3% | +25.0% | +12.5% | +18.8% |
| Revenue | ||||
| Estimate | $20000 | $70000 | $70000 | $70000 |
| Actual | $0 | $20000 | $0 | $174000 |
| Surprise | -100.0% | -71.4% | -100.0% | +148.6% |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.90 |
| Revenue | |
| Consensus | $20000 |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q3 | Jul 13, 2026 | $-1.20 | $-0.90 | -33.3 % |
| Q2 | Apr 13, 2026 | $-0.90 | $-1.20 | 25.0 % |
| Q1 | Jan 13, 2026 | $-1.05 | $-1.20 | 12.5 % |
| Q4 | Nov 28, 2025 | $-1.95 | $-2.40 | 18.8 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q3 | Jul 13, 2026 | $0 | $20.00K | -100.0 % |
| Q2 | Apr 13, 2026 | $20.00K | $70.00K | -71.4 % |
| Q1 | Jan 13, 2026 | $0 | $70.00K | -100.0 % |
| Q4 | Nov 28, 2025 | $174.00K | $70.00K | 148.6 % |